Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?
Author:
Funder
National Cancer Institute
Memorial Sloan Kettering Cancer Center
Publisher
Elsevier BV
Subject
Urology
Reference6 articles.
1. Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath Study;Bryan;Eur Urol,2021
2. Transurethral resection of bladder tumour: the neglected procedure in the technology race in bladder cancer;Mostafid;Eur Urol,2020
3. Is the en bloc transurethral resection more effective than conventional transurethral resection for non-muscle-invasive bladder cancer? A systematic review and meta-analysis;Yang;Urol Int,2020
4. Predicting grade and stage at cystoscopy in newly presenting bladder cancers—a prospective double-blind clinical study;Mariappan;Urology,2017
5. Prospective assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non–muscle-invasive bladder cancer patients candidate for repeated transurethral resection;Del Giudice;Eur Urol,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Significance of Normalized Apparent Diffusion Coefficient in the Vesical Imaging‐Reporting and Data System for Diagnosing Muscle‐Invasive Bladder Cancer;Journal of Magnetic Resonance Imaging;2023-12-28
2. The vascular and morphological characteristics of tumors under narrow-band imaging as predictors for the grade and stage of bladder cancer: a prospective and multi-center study;Annals of Medicine;2023-11-10
3. Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1;Urologic Oncology: Seminars and Original Investigations;2023-07
4. Re: Trey Durdin, Alvin Goh, Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Eur Urol 2021;80:16–7;European Urology;2022-04
5. Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?;European Urology;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3